Original filing text · Part II

Item 1 — Legal Proceedings

Cue Biopharma, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

We are not currently a party to any material legal proceedings.